GRemHAp
Hepatic Diseases in Primary Care Research Group
The Group of Hepatic Diseases in Primary Care belonging to the Metropolitan North USR of the Barcelona province was formed in 2005, being a group consolidated by IDIAP Jordi Gol and linked to the Center for Biomedical Research in the Network of Diseases Hepatic and Digestive (CIBEREHD). At the moment it is constituted by a stable group of researchers, made up of 7 doctors, a research technician, 4 nurses and a pharmacist. So far it has been characterized by the development of population studies in primary care. One of them included a total of 766 subjects being the basis of the first and only study on the prevalence of non-alcoholic fatty liver carried out in our country. Another study finalized recently with a total of 3076 subjects on the early detection of liver fibrosis in the general population. Study that has aroused much interest in the results obtained. We are currently tracking this cohort.
Group projects
|
PI: Caballería Rovira, Llorenç. Cribado poblacional de fibrosis hepática con elastografia transitoria en personas con factores de riesgo de enfermedad hepática e índice de grasa hepática elevado. Estudio de validación. Funding: Instituto de Salud Carlos III. Duration: 2019 - 2021 |
|
PI: Caballería Rovira, Llorenç. Algorithm for screening for liver fibrosis based on transient elastography in subjects with risk factors for liver disease and an increased fatty liver index. A validación study.. Funding: Gilead Sciences, S.L.U. Duration: 2019 - 2020 |
|
PI: Caballería Rovira, Llorenç. Screening for liver fibrosis. A population-based study in European countries. The LiverScreen project. Funding: Gilead Sciences, S.L.U. Duration: 2018 - 2020 |
|
PI: Expósito Martínez, Carmen. L'àcid úric com a factor de risc de la malaltia renal crònica, malaltia cardiovascular i fetge gras no alcohòlic. Funding: IDIAP Jordi Gol. Duration: 2017 - 2019 |
|
PI: Caballería Rovira, Llorenç. Valor predictivo de la elastografía hepática transitoria respecto a la enfermedad hepática y cardiovascular. Funding: Instituto de Salud Carlos III. Duration: 2015 - 2019 |
The group participates in the following publications
|
Bataller R, Cabezas J, Aller R, Ventura-Cots M, Abad J, Albillos A, Altamirano J, Arias-Loste MT, Bañares R, Caballería J, Caballería L, Carrión JA, Diago M, Fernández Rodríguez C, Gallego R, García-Cortes M, García-Monzón C, Genescà J, Ginés P, Hernandez-Guerra M, Jorquera F, Lligoña A, Molina E, Pareja MJ, Planas R, Tomé S, Salmerón J, Romero-Gómez M. Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. Gastroenterol Hepatol. 2019 Dec; 42(10):657-676. doi:10.1016/j.gastrohep.2019.09.006. Epub 2019 Nov 23. PMID:31771785. IF: 1,126. |
|
Caballeria L, Augustin S, Broquetas T, Morillas RM, Vergara M, Virolés S, Hernández MR, Serra I, Goday A, Vila L, Siso-Almirall A, Solans R, Fernández-Real JM, Carrión JA, Graupera I, Ginès P. Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care. Med Clin (Barc). 2019 Aug; 153(4):169-177. doi:10.1016/j.medcli.2019.01.030. Epub 2019 Jun 06. PMID:31178295. IF: 1,277. |
|
Caballeria L, Torán P. The fatty liver epidemic: An analysis from the primary care. Aten Primaria. 2019 Nov; 51(9):525-526. doi:10.1016/j.aprim.2019.09.002. Spanish. PMID:31718777. IF: 1,346. |
|
Expósito C, Pera G, Rodríguez L, Arteaga I, Martínez A, Alumà A, Doladé M, Torán P, Caballeria L. Prevalence of Early Chronic Kidney Disease and Main Associated Factors in Spanish Population: Populational Study. J Clin Med. 2019 Sep; 8(9). doi:10.3390/jcm8091384. Epub 2019 Sep 04. pmc:PMC6780839. PMID:31487800. IF: 5,688. |
|
Serra-Burriel M, Graupera I, Torán P, Thiele M, Roulot D, Wai-Sun Wong V, Neil Guha I, Fabrellas N, Arslanow A, Expósito C, Hernández R, Lai-Hung Wong G, Harman D, Darwish Murad S, Krag A, Pera G, Angeli P, Galle P, Aithal GP, Caballeria L, Castera L, Ginès P, Lammert F; investigators of the LiverScreen Consortium. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia. J. Hepatol. 2019 Dec; 71(6):1141-1151. doi:10.1016/j.jhep.2019.08.019. Epub 2019 Aug 27. PMID:31470067. IF: 18,946. |
Indicators
|
Indicator |
2019 |
|---|---|
|
Researchers with PhD |
5 |
|
Total number of projects in which group members have participated |
5 |
|
Total number of projects in which the PI of the project has belonged to the group |
5 |
|
Total Funding |
290.045,00€ |
|
Scientific publications in indexed journals |
5 |
|
Total Impact factor |
28,38 |
|
Nº of articles in Q1 journals |
2 |
|
Q1 IF |
24,634 |
|
Nº of articles in Q2 journals |
0 |
|
Q2 IF |
